Drug Trial Radar · NCT05147233
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Last checked: Nov 19, 2026Latest source record: Jul 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
241
Actual
Start
Jun 24, 2022
Primary completion
Jun 22, 2023
Study completion Jul 3, 2023
Sponsor
- Lead sponsor
- OculisIndustry
- Sponsor type
- Industry
- First posted
- Dec 7, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was a randomized, double-masked, vehicle-controlled, Phase 3 study evaluating the efficacy and safety of OCS-01 QD compared to vehicle in the treatment of inflammation and pain following cataract surgery.
Conditions
- Inflammation Eye Pain
- Postoperative Cataract
Interventions
OCS-01Drug
Dexamethasone ophthalmic suspension, 1.5%
VehicleDrug
Vehicle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absence of Anterior Chamber Cells at Visit 6.Time frame: Day 15
- Absence of Ocular Pain at Visit 4.Time frame: Day 4
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Oculis Site 16
Chandler, Arizona
Oculis Site 28
Phoenix, Arizona
Oculis Site 8
Fayetteville, Arkansas
Oculis Site 9
Inglewood, California
Oculis Site 23
Newport Beach, California
Oculis Site 26
Petaluma, California
Oculis Site 24
San Pedro, California
Oculis Site 22
Westminster, California
Oculis Site 11
Fort Collins, Colorado
Oculis Site 12
Tamarac, Florida
Oculis Site 17
Morrow, Georgia
Oculis Site 20
Louisville, Kentucky
Oculis Site 5
St Louis, Missouri
Oculis Site 3
Washington, Missouri
Oculis Site 13
Kinston, North Carolina
Oculis Site 6
Brecksville, Ohio
Oculis Site 14
Cincinnati, Ohio
Oculis Site 25
Eugene, Oregon
Oculis Site 7
Kingston, Pennsylvania
Oculis Site 4
Austin, Texas
Oculis Site 10
Houston, Texas
Oculis Site 2
San Antonio, Texas
Oculis Site 31
San Antonio, Texas
Oculis Site 27
Salt Lake City, Utah
Oculis Site 30
Lynchburg, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.